Gastrointestinal Drug Development: New and Existing Therapies (2001)

Although the GI drugs market is growing rapidly, at present, there is a distinct lack of targeted drug discovery for many gastrointestinal disorders, with few novel drugs reaching the marketplace.

SMi’s latest Pharmaceuticals conference, ‘Gastrointestinal Drug Development: New & Existing Therapies’ focuses on the challenges faced in gastrointestinal drug development and evaluation. The conference will examine current as well as emerging GI therapies and the strategic development of GI therapeutics to create successful drug portfolios. This conference will make sure that you are kept fully up to date with all the scientific and business news from the field of gastrointestinal drug development.

As you can see from the programme, SMi have strived to, and succeeded in getting expert speakers to discuss these key issues at the conference. These speakers will provide you with valuable insights into how to get the most out of the GI market through their presentations and discussions.

As with all SMi’s Pharmaceutical events, there will also be plenty of networking opportunities available allowing you to discuss the main issues with colleagues from all over the world.